DCF — ARROWHEAD REGIONAL MEDICAL CENTER
Enterprise Value: $-359.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-359.4M
Enterprise Value
$-120.2M
PV of Cash Flows
$-239.2M
PV of Terminal Value
$-385.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $418.6M | $-18.8M | -5.0% | $-36.6M | $-33.2M |
| Year 2 | $431.1M | $-15.1M | -4.0% | $-33.3M | $-27.6M |
| Year 3 | $444.0M | $-11.1M | -3.0% | $-29.9M | $-22.5M |
| Year 4 | $457.4M | $-9.1M | -2.0% | $-28.5M | $-19.5M |
| Year 5 | $471.1M | $-8.2M | -2.0% | $-28.2M | $-17.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-359.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$406.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000000615213015
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5